Brian Snell, 54, was getting ready for a Rascal Flatts concert June 9 when he developed a terrible headache. The next thing Snell knew, he was on his back in the shower and couldn’t move his legs.
Aman Patel, MD
Aman Patel, MD
Director of Cerebrovascular and Endovascular Neurosurgery
Co-Director of the Neuroendovascular Program
Departments, Centers, & Programs:
Mass General Neurosurgery
55 Fruit St.
Boston, MA 02114
- MD, UCLA School of Medicine
- Residency, UCLA Medical Center
- Fellowship, UCLA Medical Center
American Board Certifications
- Neurological Surgery, American Board of Neurological Surgery
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Patel's research interests focus on the endovascular treatment of stroke, carotid and intra-arterial stents, cerebral aneurysm treatment, aneurysm morphology and flow dynamics, and hemorrhagic stroke treatment.
He is involved in multiple National Institutes of Health (NIH) and industry sponsored multi-center studies that investigate treatments related to ischemic stroke, hemorrhagic stroke, new devices and new techniques. He was an early investigator in the initial post-market evaluation of carotid artery stenting (SAPPHIRE) and in the first study on the endovascular treatment of intracranial atherosclerotic stenosis (SAMMPRIS). Some of his active studies include: the Penumbra Liberty trial investigating a new stent device for the treatment of cerebral aneurysms and an NIH trial site studying the surgical treatment of cerebral hemorrhage.
He also actively maintains a clinical database evaluating clinical outcomes and treatments. This database has led to multiple peer reviewed publications.
- Nov | 18 | 2014
“One treatment doesn’t work for every patient. I am committed to strengthening our multidisciplinary team and working together to carefully assess each case so we can provide the highest quality care and increase patient volume,” says Dr. Patel